281 followers
RT @FrontEndocrinol: New Research: GLP-1 RAs and SGLT-2 Inhibitors for Insulin Resistance in Nonalcoholic Fatty Liver Disease: Systematic R…
RT @FrontEndocrinol: New Research: GLP-1 RAs and SGLT-2 Inhibitors for Insulin Resistance in Nonalcoholic Fatty Liver Disease: Systematic R…
New Research: GLP-1 RAs and SGLT-2 Inhibitors for Insulin Resistance in Nonalcoholic Fatty Liver Disease: Systematic Review and Network Meta-Analysis: Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and… https://t.co/kGXAXdxZ6w #Endocrinol